Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
Background Immunotherapies, such as immune checkpoint inhibitors and adoptive cell therapies, have revolutionized cancer treatment and resulted in complete and durable responses in some patients. Unfortunately, most immunotherapy treated patients still fail to respond. Absence of T cell infiltration...
Main Authors: | Valentyna I Fesenkova, Aaron E Fan, Diane Addis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/8/2/e001224.full |
Similar Items
-
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
by: Jingjing Zhu, et al.
Published: (2017-11-01) -
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display
by: Stina L. Wickström, et al.
Published: (2019-12-01) -
Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
by: Samuel I. Kim, et al.
Published: (2021-02-01) -
Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer
by: Justin T. Gibson, et al.
Published: (2020-10-01) -
A novel cancer immunotherapy using tumor-infiltrating B cells in the APCmin/+ mouse model.
by: Xinying Wang, et al.
Published: (2021-01-01)